Exploring Transparency and Drug Pricing Policies

This chapter explores new research on drug pricing, emphasizing the role of transparency in AI models for Alzheimer's treatment. It reviews proposed reforms like the Most Favored Nation policy and their potential effects on drug costs and negotiations in the U.S., as well as global implications.